Processa pharmaceuticals to present at ld micro virtual investor conference on june 9, 2021, at 1:30pm et

Hanover, md, june 07, 2021 (globe newswire) -- processa pharmaceuticals, inc. (nasdaq: pcsa), (“processa” or the “company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have unmet medical needs, announced today that management will present at:
PCSA Ratings Summary
PCSA Quant Ranking